Announcement on Resignation of Senior Management Members
Filed with SSE · · 2 pages · Chinese
Shanghai Shyndec Pharmaceutical Co., Ltd. on 6ix
Earlier from Shanghai Shyndec Pharmaceutical
- Announcement on Resolutions of the 24th (Extraordinary) Meeting of the 8th Board of Directors
- Announcement on the Voluntary Information Disclosure of Drug Passing the Consistency Evaluation for Generic Drugs
- Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025
- Announcement on the Wholly-owned Subsidiary Obtaining the Approval Notice for Drug Supplementary Application
- Announcement on Implementation of Semi-annual Dividend Distribution for 2025
Later from Shanghai Shyndec Pharmaceutical
- Announcement on Wholly-owned Subsidiary Obtaining Approval for Marketing of Chemical APIs
- Announcement on the Progress and Transaction Results of the Public Listing Transfer of Subsidiary Equity
- Announcement on Prospective Winning of the 11th National Centralized Drug Procurement
- Report for Q3 2025
- Announcement on Progress in Public Listing and Transfer of Equity in a Holding Subsidiary and Completing Industrial and Commercial Change
Follow Shanghai Shyndec Pharmaceutical into a list and get an email when it puts out news.
Follow Shanghai Shyndec Pharmaceutical